Marilyn R Kehry

Title: The Innovative Contributions of Marilyn R Kehry

Introduction

Marilyn R Kehry is a prominent inventor based in Danbury, CT (US). She has made significant contributions to the field of biotechnology, particularly in the area of B cell research. With a total of 3 patents to her name, Kehry's work has advanced our understanding of immune responses and therapeutic applications.

Latest Patents

One of her latest patents is titled "B cell culture system comprising high density membrane bound CD40 ligand." This invention provides methods for proliferating B cells, enabling the acquisition of large quantities of these cells. Additionally, it outlines methods for differentiating a proliferating B cell population into antibody-producing cells. Another notable patent is "High throughput compatible assay for receptor-TRAF interactions." This patent discloses a high throughput assay useful for identifying specific antagonists of TRAF-receptor interactions. The modular flexibility of this assay allows for modifications to measure interactions of any TNF receptor cytoplasmic domain with various TRAF proteins.

Career Highlights

Marilyn R Kehry is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where she continues to innovate and contribute to the field. Her work has been instrumental in developing new methodologies that enhance the understanding of immune cell functions.

Collaborations

Throughout her career, Kehry has collaborated with notable colleagues, including Brian Castle and Steven S Pullen. These collaborations have further enriched her research and contributed to the advancement of her projects.

Conclusion

Marilyn R Kehry's innovative work in biotechnology and her contributions to B cell research exemplify her dedication to advancing scientific knowledge. Her patents reflect her commitment to improving therapeutic strategies and understanding immune responses.